Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

Benboubker L;Dimopoulos MA;Dispenzieri A;Catalano J;Belch AR;Cavo M;Pinto A;Weisel K;Ludwig H;Bahlis N;Banos A;Tiab M;Delforge M;Cavenagh J;Geraldes C;Lee JJ;Chen C;Oriol A;de la Rubia J;Qiu L;White DJ;Binder D;Anderson K;Fermand JP;Moreau P;Attal M;Knight R;Chen G;Van Oostendorp J;Jacques C;Ervin-Haynes A;Avet-Loiseau H;Hulin C;Facon T; ;;
The New England journal of medicine 2014 Vol. 371 pp. -
250
l2014thelenalidomide

Abstract

As compared with MPT, continuous lenalidomide-dexamethasone given until disease progression was associated with a significant improvement in progression-free survival, with an overall survival benefit at the interim analysis, among patients with newly diagnosed multiple myeloma who were ineligible f …

Keywords

research support non-u.s. gov't Comparative Study Randomized Controlled Trial initials='g' affs=[] is_editor=false suffix=none equal_contrib=false) initials='j' initials='a' initials='h' initials='b' initials='n' author(firstnames='w' initials='w' initials='p' initials='l' initials='k' author(firstnames='j' author(firstnames='g' author(firstnames='h' author(firstnames='p' author(firstnames='l' author(firstnames='a' initials='d' initials='s' initials='m' initials='o' initials='f' initials='c' initials='i' initials='r' initials='e' initials='v' investigators=[author(firstnames='c' author(firstnames='s' author(firstnames='n' author(firstnames='c' author(firstnames='t' initials='t' author(firstnames='m' author(firstnames='d' author(firstnames='e' author(firstnames='b' author(firstnames='k' author(firstnames='r' lastname='campbell' author(firstnames='v' initials='z' lastname='chen' lastname='leblanc' pmid:25184863 doi:10.1056/nejmoa1402551 lotfi benboubker meletios a dimopoulos collabauthor(name='first trial team' lastname='forsyth' lastname='presgrave' lastname='szer' lastname='durrant' lastname='mollee' lastname='coghlan' lastname='wellwood' lastname='cannell' lastname='prince' lastname='eek' lastname='horvath' lastname='harrison' lastname='renwick' lastname='thaler' lastname='petzer' lastname='kasparu' lastname='bauernhofer' lastname='meran' lastname='fridrik' lastname='balcke' lastname='gisslinger' lastname='greil' lastname='doyen' lastname='meuleman' lastname='pierre' lastname='vekemans' lastname='demuynck' lastname='wu' lastname='van droogenbroeck' lastname='schots' author(firstnames='f' lastname='offner' lastname='van de velde' lastname='tosikyan' lastname='shustik' lastname='song' lastname='lemieux' lastname='minuk' lastname='lalancette' lastname='cheung' lastname='noble' lastname='vanderjagt' lastname='desjardins' lastname='aucoin' lastname='dueck' lastname='yee' lastname='reiman' lastname='kouroukis' lastname='assouline' lastname='al-tourah' lastname='lu' lastname='liu' author(firstnames='z' lastname='shen' lastname='alexis' lastname='audhuy' author(firstnames='i' lastname='azais' lastname='belhadj' lastname='benramdane' lastname='tempescul' lastname='boue' lastname='rose' lastname='bourhis' lastname='bouscary' lastname='caillot' lastname='casassus' lastname='de renzis' lastname='genet' lastname='de revel' lastname='dib' lastname='dorvaux' lastname='etienne' lastname='gabriel' lastname='eisenmann' author(firstnames='o' lastname='fitoussi' lastname='garderet' lastname='gaspard'

Citation

ID: 269037
Ref Key: l2014thelenalidomide
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
269037
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet